Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Autor:	Molebogeng Xheedha Rangaka, Takashi Yoshiyama, Lucy Chesire, Solange Cavalcante, Holger J. Schünemann, Ibrahim Abubakar, Marieke J. van der Werf, Nobuyuki Nishikiori, Philip A. LoBue, Monica Sañé Schepisi, Robert J. Wilkinson, Anna H. van’t Hoog, Susana Marta Borroto Gutierrez, Lisa J. Nelson, Lisa D. Rotz, Margaret Gale-Rowe, Alwyn Mwinga, Sandra V. Kik, Marije Vonk Noordegraaf-Schouten, Diana Weil, Cynthia B.E. Chee, Andreas Reis, Dick Menzies, Mario C. Raviglione, Malgorzata Grzemska, Alberto Matteelli, Nathan Ford, Natalia Vezhnina, Helen R. Stagg, Saskia Den Boon, Chris Gilpin, Enrico Girardi, Jean-Pierre Zellweger, Guy B. Marks, Draurio Barreira, Ya Diul Mukadi, C. Robert Horsburgh, Knut Lönnroth, Mohamed Abdel Aziz, Andreas Sandgren, Annabel Baddeley, Richard E. Chaisson, Rolando Cedillos, Giovanni Sotgiu, Davide Mosca, Dennis Falzon, Surender Kumar Sharma, Erlina Burhan, Jay K. Varma, Ross J Harris, Mukund Uplekar, Haileyesus Getahun, Karin Weyer, Wim Vandevelde, Timothy R. Sterling, Alison D. Grant, Asker Ismayilov, Masoud Dara, Judith Bruchfeld, Darshini Govindasamy, Anouk M. Oordt-Speets, Ernesto Jaramillo, Constantia Voniatis, Christian Lienhardt, Un Yeong Go, Giovanni Battista Migliori, Elizabeth L. Corbett, Justin T Denholm, Femke van Kessel, Gerard De Vries, Tamara Tayeb, Katharina Kranzer
Přispěvatelé:	Other departments, Global Health
Rok vydání:	2021
Předmět:	Gerontology Thoracic Antitubercular Agents Antirheumatic Agents/therapeutic use HIV Infections Comorbidity Kidney Failure Drug Users Substance-Related Disorders/epidemiology Mass Screening Medicine Chronic Human Biology & Physiology Evidence-Based Medicine Latent tuberculosis biology Coinfection Medicine (all) Disease Management Homeless Persons Antirheumatic Agents Emigrants and Immigrants Health Personnel Humans Interferon-gamma Release Tests Isoniazid Kidney Failure Chronic Latent Tuberculosis Practice Guidelines as Topic Prisoners Public Health Radiography Thoracic Renal Dialysis Rifampin Risk Assessment Silicosis Substance-Related Disorders Transplant Recipients Tuberculin Test Tumor Necrosis Factor-alpha World Health Organization Pulmonary and Respiratory Medicine HIV Infections/epidemiology Ill-Housed Persons Latent Tuberculosis/diagnosis Perspectives medicine.drug Model organisms medicine.medical_specialty Tuberculosis Isoniazid/therapeutic use Antitubercular Agents/therapeutic use Immunology Tuberculin Infectious Disease Mycobacterium tuberculosis Silicosis/epidemiology Internal medicine Coinfection/epidemiology Kidney Failure Chronic/epidemiology Mass screening Tumor Necrosis Factor-alpha/antagonists & inhibitors business.industry FOS: Clinical medicine Rifampin/analogs & derivatives medicine.disease biology.organism_classification bacterial infections and mycoses Rifapentine Radiography Transplantation business Rifampicin
Zdroj:	European respiratory journal, 46(6), 1563-1576. European Respiratory Society The European Respiratory Journal Getahun, H, Matteelli, A, Abubakar, I, Aziz, M A, Baddeley, A, Barreira, D, Den Boon, S, Borroto Gutierrez, S M, Bruchfeld, J, Burhan, E, Cavalcante, S, Cedillos, R, Chaisson, R, Chee, C B-E, Chesire, L, Corbett, E, Dara, M, Denholm, J, de Vries, G, Falzon, D, Ford, N, Gale-Rowe, M, Gilpin, C, Girardi, E, Go, U-Y, Govindasamy, D, Grant, A D, Grzemska, M, Harris, R, Horsburgh, C R, Ismayilov, A, Jaramillo, E, Kik, S, Kranzer, K, Lienhardt, C, LoBue, P, Lönnroth, K, Marks, G, Menzies, D, Migliori, G B, Mosca, D, Mukadi, Y D, Mwinga, A, Nelson, L, Nishikiori, N, Oordt-Speets, A, Rangaka, M X, Reis, A, Rotz, L, Sandgren, A, Sañé Schepisi, M, Schünemann, H J, Sharma, S K, Sotgiu, G, Stagg, H R, Sterling, T R, Tayeb, T, Uplekar, M, van der Werf, M J, Vandevelde, W, van Kessel, F, van't Hoog, A, Varma, J K, Vezhnina, N, Voniatis, C, Vonk Noordegraaf-Schouten, M, Weil, D, Weyer, K, Wilkinson, R J, Yoshiyama, T, Zellweger, J P & Raviglione, M 2015, ' Management of latent Mycobacterium tuberculosis infection : WHO guidelines for low tuberculosis burden countries ', European Respiratory Journal, vol. 46, no. 6, pp. 1563-1576 . https://doi.org/10.1183/13993003.01245-2015
ISSN:	0903-1936
DOI:	10.25418/crick.15277998
Popis:	Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses to previously acquired Mycobacterium tuberculosis infection without clinical evidence of active tuberculosis (TB). Here we report evidence-based guidelines from the World Health Organization for a public health approach to the management of LTBI in high risk individuals in countries with high or middle upper income and TB incidence of Guidelines on LTBI for low TB incidence countries – essential element of the @WHO #EndTB strategy and TB elimination http://ow.ly/RW8xn
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187409e0f497106e513edd06d3443058 Zobrazit plný text záznamu